Introduction and background
Depression among people with chronic conditions, including epilepsy, is recognized to be a major concern. Depression is the most common psychiatric disorder among people with epilepsy (PWE) and is negatively associated with heath quality of life. 1, 2 Additionally, depression often is not recognized or diagnosed among PWE. 3 As more attention has been brought to this problem, several standard depression measures have been tested for reliability and validity as screening measures in this population, including a measure specifically designed for people with epilepsy. The Beck Depression Inventory (BDI), 4 Center for Epidemiological Study of Depression scale (CES-D), 5 Patient Health Questionnaire (PHQ-9), 6, 7 and Neurological Disorders Depression Inventory for Epilepsy (NDDI-E) 8 have all been used to assess depressive symptoms among people with epilepsy. [9] [10] [11] Jones and colleagues 10 found that both the BDI and CES-D were able to identify depression with good specificity and sensitivity in a sample of people with epilepsy who attended a tertiary outpatient clinic. Similar results were found with the PHQ-9. 11 The NDDI-E was specifically designed to measure depressive symptoms among people with epilepsy. People with epilepsy often experience symptoms due to their condition or medication side-effects, such as memory problems, decreased concentration, fatigue, and sleep disturbances, 12, 13 that overlap with depressive symptoms. The NDDI-E, therefore, includes items assessing symptoms of depression that are distinct from these overlapping symptoms. 8 Friedman and colleagues 9 found that screening with the NDDI-E in an epilepsy clinic increased the detection of depression significantly. Recently, the psychometric properties of depression scales have been examined using contemporary measurement methodology, such as item response theory and Rasch measurement models. Compared to traditional measurement theory, a requirement of Rasch models is that item calibrations are invariant across samples; in other words, item calibrations for measuring depressive symptoms are not sample dependent when good model-data fit is obtained. [14] [15] [16] [17] 19, 20 and coronary heart disease. 21 To our knowledge, Rasch analyses of depression scales among people with epilepsy have not been conducted. The primary purpose of this study was to use Rasch analyses in order to evaluate and compare the psychometric properties of three depression scales in a sample of people with epilepsy and depression who participated in an intervention designed to reduce depressive symptoms. Additionally, we examined differences in item functioning based on time (pretest and posttest administrations of the instruments). The following research questions were addressed: (1) Do the items function as intended to define measures of depression among people with epilepsy? and (2) Does the intervention program (UPLIFT) affect how the items functioned before and after the intervention?
Methods

Sample
This study is part of a larger study, funded by the Centers of Disease Control and Prevention, that pilot tested the feasibility and efficacy of the Project UPLIFT (Using Practice and Learning to Increase Favorable Thoughts) intervention. 22 Following Institu- 23 Individuals reporting active suicidal ideation were ineligible to participate in the study. All participants provided written informed consent.
Project UPLIFT
Project UPLIFT is a Cognitive Behavioral Therapy and mindfulness-based program for people with epilepsy and depression that was delivered over the phone or internet to groups of about seven participants. The program includes 8 weekly sessions that require about an hour of the participants' time per week. Each session involves a check-in, instruction on the week's topic, skill practice, and group discussion. Phone group participants take part in a weekly conference call and internet group participants interact over a secure website. Program components were designed to increase knowledge about depression and build skills to cope with depressive symptoms. CBT activities include thought monitoring and stopping, problem identification, relaxation, and goal setting. Mindfulness training involves mindful attention, meditations, recognition of the impermanent nature of thoughts, and awareness of pleasure. More detail on the Project UPLIFT program is provided elsewhere. 22, 24 The pilot study was evaluated using a crossover design. 25 Participants were randomized into two groups, initial treatment group and waitlist control group, and then assessed at baseline. The initial treatment group received the treatment following the baseline assessment, during which time the waitlist condition served as a treatment-as-usual (TAU) control group. Both groups were assessed at an interim time point. The TAU waitlist group then received the intervention. Finally, both groups were assessed with a follow-up survey. For this analysis, we used the assessments of both groups at pretest before the intervention (baseline for the initial treatment group and interim assessment for the TAU waitlist group) and posttest immediately after the intervention (interim assessment for the initial treatment group and follow-up for the TAU waitlist group).
For each assessment, trained interviewers read the instruments to the participants over the phone. The surveys assessed depressive symptoms, satisfaction with life, purpose in life, depression coping self-efficacy, quality of life, seizure severity, and demographic information. Only the depression scales are examined here. Participants received $25 for each assessment completed. In the pilot study, Project UPLIFT was effective in reducing depressive symptoms and increasing knowledge of depression and skills for improving mood. 22 
Measures
Modified Beck Depression Inventory (mBDI)
The mBDI 26 is a modified version of the BDI 4 that includes a positive feeling choice for each of the 21 items in addition to the choices reflecting the negative aspects of each symptom. Thus, each item in the mBDI includes 5 statements that range from 0 (positive experience) to 4 (severe negative experience).
Patient health questionnaire (PHQ-9)
The PHQ-9 6 is a 9-item scale that is based on the diagnostic criteria for depression found in the American Psychological Association's Diagnostic and Statistical Manual (DSM-IV). 27 The items are rated on a 4-point scale of how often a person has been bothered by each symptom in the past two weeks (0 being ''never'' and 3 being ''nearly everyday'').
Neurological disorders depression inventory for epilepsy (NDDI-E)
The NDDI-E is a 6-item scale that measures symptoms of depression that are distinct from symptoms that may result from side-effects of anti-epileptic medication or having epilepsy, such as memory problems, decreased concentration, fatigue, and sleep disturbance. 8 The items of the NDDI-E are measured on a 4-point Likert scale reflecting how often a person experienced each depressive symptom in the past two weeks (1 being ''never'' and 4 being ''always or often'').
Data analysis
Descriptive statistics were run in PASW Statistics 18. These included demographic and scale descriptive statistics. Rasch analyses were conducted using the Facets computer program (Version 3.66.2). The Rasch measurement model is an item response theory model that allows for an ordering of individuals and items along a unidimensional latent variable. The probability of a person endorsing a particular response option is based on the person's ability and the item difficulty.
14 In this analysis, the latent variable is level of depressive symptoms, the person's ''ability'' refers to a participant's level of depressive symptoms, and the item difficulty indicates the severity of depressive symptoms represented by an item. Two sets of models were run. First, the BDI, PHQ-9, and NDDI-E were analyzed separately using a rating scale model, which is used when all items within an instrument have the same number of response choices. Second, the items from all three scales were entered into the same model; therefore a partial credit multifaceted Rasch model was used to take into account the different number of response options for each scale. Running all of the items together allowed us to assess how well the different scales covered the latent variable of depression for PWE. A facet was included for each of the following: participants' level of depressive symptoms, difficulty in endorsing an item, and time (represented by the pretest and posttest). The model can be written as follows:
where P njik , the probability of participant n endorsing answer choice k on an item i at time j; P nkiÀ1 , the probability of participant n endorsing answer choice kÀ1 on item i at time j; Q n , the level of depressive symptoms for participant n; d i , the difficulty of endorsing item i; D j , the time effect (pretest and posttest); t ik , the difficulty of endorsing answer choice k compared to answer choice kÀ1 on the items. The Facets software calculates summary and fit statistics separately for each facet. Differential Item Functioning (DIF) occurs when the location of an item on the latent variable changes depending on person subgroups. 28 In this study, DIF analysis was conducted to determine if the items were ordered differently based on time (pretest and posttest). DIF can be conceptualized as an interaction between time and items (d i *D j ). This means that item location is dependent on time. Part of the DIF analysis involves t-tests comparing the average score on each item at pretest and posttest.
Results
Sample
A total of 53 people were enrolled in the Project UPLIFT pilot study and randomized to the initial UPLIFT treatment condition or the TAU waitlist condition. This study utilized a sample size of 44 individuals (23 in the treatment and 21 in the TAU waitlist groups) who completed the assessment prior to participating in the intervention. Of these 44 individuals, 38 people (19 in each of the treatment and TAU waitlist groups) completed the assessment immediately post-intervention. The majority of the participants were female, white, single, lived with family, completed at least some college, and did not work (see Table 1 ). About two-thirds of the sample had experienced a seizure in the past month.
Descriptive statistics
Descriptive statistics for the mBDI, PHQ-9, NDDI-E, and combined scales are shown in Table 2 . As expected, the mean depressive symptoms for each scale decreased from pretest to posttest. The effect sizes, in logits, are 0.37 for the mBDI, 0.17 for the PHQ-9, 0.29 for the NDDI-E, and 0.33 for the combined scales. The Rasch measures accounted for 27.94% of the variance of the mBDI scale, 56.27% for the NDDI-E, 46.08% for the PHQ-9, and 43.53% for all the scale items combined. Values above 20% are considered to reflect an acceptable unidimensional scale for Rasch analysis. 29 Fig. 1 shows the logit scale which serves as the ruler along which the facets (persons and items) are calibrated so that they can be placed on the same scale. The second column displays the participants' level of depression. More depressed individuals appear at the top of the variable map while individuals with lower levels of depression appear at the bottom. The third column displays the location of all of the depression items from the three scales combined. The items range from about À1.75 to 1.25 logits on the latent variable, with the majority clustered around À0.5 to 1.00 logits. The fourth through sixth columns show the locations of the depression items from each of the three scales separately. Each item is identified by the first letter of the scale it is from and the item number (ex. B1 is the first item from the mBDI scale). The item that was hardest to endorse, indicating that the respondent had to experience a high level depressive symptoms in order to say they felt this way, was the item on the PHQ-9 assessing how often a participant had ''thoughts that you would be better off dead or of hurting yourself in some way.'' The easiest item to endorse was the NDDI-E item assessing the frequency that individuals felt frustrated. The mBDI tended to be clustered between À0.5 and 0.5 logits on the latent variable, while the items of the PHQ-9 and NDDI-E showed a greater spread. Almost all of the NDDI-E items were under zero logits on the latent variable. The exception is the item ''I'd be better off dead,'' which is located much higher on the latent variable, indicating that it is difficult to endorse.
Variable map and Rasch analysis
The variable map (Fig. 1) is useful for comparing the spread of the items compared to the individuals, which indicates how well SD, standard deviation; n, number of participants. B2 B7  B9  B5  B12 B14  B1 B11  P8  B18 B4  B13 B15 B8  P6  0  B19  P1  B20  P2  B16 B21 B3 B6 P7  B10  N2  B17  P3 P5  N3  N1 the items and the sample are matched. Looking at the combined scales, there is good overall targeting between the items and the persons as denoted by the overlap in spread. The individuals do not overlap with the items that indicate more severe depression, such as those related to suicide. This gap is to be expected since persons with severe depression or suicidal ideation were not eligible for this study. Comparing the individual scales, some scales fill in the gaps for others. The items of the mBDI are clustered rather closely together and match fairly well to the persons. The PHQ-9 has a wider range and is a better match for the sample. The NDDI-E also has a wide range; however, due to the relatively low number of items, there are several gaps. The mBDI and PHQ-9 help to fill in the top gap and the PHQ-9 helps somewhat to fill in the lower gap. The summary statistics for persons, items, and time are presented in Table 3 . Persons are the focus of the measurement model and all other facets are anchored at a mean of zero to provide a frame of reference. The mean level of depression for participants ranges from À0.38 to À0.91 logits. The mean Infit and Outfit scores for persons, items, and time are close to one, indicating acceptable model-data fit. The standard deviations for the person fit statistics are slightly higher than expected (SD are expected to be 0.20). This additional variation in persons indicates that some people may not be responding to the items as expected. The reliability of person spread, which is similar to Cronbach's alpha, is above 0.80 and statistically significant for each scale, which indicates good spread of people along the latent variable. The reliability of items and time spread is also good (above 0.70). The significant separation of reliability for time indicates that UPLIFT participants experienced a significant decrease in depression symptoms from pretest to posttest. 
Differential item functioning
An analysis of Differential Item Functioning, the interaction between items and time, indicated that the items functioned similarly at pretest and posttest. Almost all of the posttest items are lower on the latent variable compared to the pretest items. Three items, however, functioned differently than expected at posttest. Compared to the mean depression score on pretest, participants had a significantly higher mean depression score for the following three items at posttest: mBDI18 (appetite), mBDI21 (sex drive), and PHQ3 (''Trouble falling or staying asleep, or sleeping too much''). Additionally, the mean depression score for mBDI11 (irritation) was significantly lower at posttest than expected.
Discussion
The purpose of this study was to examine how the items from three depression scales functioned, using data from an intervention study that has been shown to effectively reduce depressive symptoms among people with epilepsy. Additionally, we were interested in assessing differences in item functioning from pretest to posttest.
Addressing the first research question, the variable map and other Rasch measurement model analyses indicate that the three depression scales functioned as intended among this sample. The variable map provides a useful visual for comparing how the three depression scales functioned for people with epilepsy and depression. Combining all of the items from each scale proved to be quite informative in determining how well each scale was matched with the sample on the latent variable of depression. Overall, the scales were well targeted for the sample, with items from different scales filling in gaps in the other scales.
None of the scales covered the full range of depression on their own, however. This suggests that choosing multiple depression scales for studies may be important to capture the full range of the latent variable for people with epilepsy. This is particularly true for the NDDI-E, which has a gap in the middle range of depression. The NDDI-E is designed to be a brief screening tool; 8 therefore following up with another depression scale or a psychiatric structured interview may worthwhile. Unlike traditional measurement analyses, the Rasch models allowed us to examine individuals as well as the overall group. Person fit analyses provide a framework for examining in detail unexpected item responses within each of the depression scales that may be useful in obtaining a deeper understanding of how effective the intervention was in changing particular self-reported behaviors. The overall effect of the UPLIFT program was significant for the group from pretest to posttest, and the individual level analyses provided the opportunity for an in-depth exploration of each participant's responses on each item. Additional qualitative analyses can be conducted with individuals exhibiting unusual response patterns on the three depression scales.
The Rasch analysis also allowed for an examination of how the items functioned at pretest and posttest, which demonstrates its usefulness in examining change over time for intervention trials. The results support the effectiveness of the Project UPLIFT program in reducing depressive symptoms among people with epilepsy. However, the item order was not completely invariant over time. Three items, related to appetite, sex drive, and sleep, had higher mean depression scores at posttest compared to pretest. These symptoms could be attributed to side-effects from antiepileptic medications [30] [31] [32] and, if so, would not necessarily be impacted by the intervention. The scores for these items, however, are not expected to increase; the higher mean score at posttest may suggest that people were not giving ''social desirable'' responses and telling us everything was better. In contrast, the other mood related items did decrease from pretest to posttest. These symptoms may be more amenable to change from a mindfulness-based intervention, such as Project UPLIFT. Mindfulness teaches individuals to become aware of and acknowledge their thoughts, but release attachments to thoughts and suffering. 33 Therefore, mindfulness training may allow participants to more readily let go of feelings of irritation and worthlessness.
Limitations
One limitation of this study is the small sample size, which is common for intervention pilot studies. Therefore, the results, particularly the DIF comparisons of individual items, should be interpreted with caution. While Rasch analyses are often conducted on large samples, utilizing a small sample enabled us to look in more detail at the characteristics of the individuals involved in the program. A strength of Rasch analyses is that they are sample-free; however as an ideal-type model, the application of these results to another sample would represent a hypothesis. Therefore, given the small sample size, replication in a larger sample would be useful. A second limitation is that participants were screened using the CES-D, which is not included in this analysis because it was not administered at the same time as the other three depression scales. Finally, the sample was drawn from one tertiary epilepsy clinic; therefore the results may not be generalizable to the broader population of people with epilepsy.
Conclusion
This study demonstrated how Rasch analyses of three depression scales can provide insight into the depressive symptoms experienced by people with epilepsy. Additionally, it showed the usefulness in using Rasch analysis to examine how an intervention affects particular symptoms of depression. Rasch analysis would be useful in future research to explore how to fill in where scales have gaps in measuring depressioneither through additional items or additional scales. The depression scales could also be compared to a psychiatric structured interview to see if they perform in a similar manner. Another area of potential inquiry is to utilize Rasch analyses and qualitative methods to examine the reasons for differences between people in how they responded to the individual items. For people with epilepsy in particular, Rasch analyses could be useful in further exploration of the symptoms that overlap between depression and epilepsy.
